Royal College of Surgeons in Ireland
Browse
DOCUMENT
LC3B globular structures correlate with survival in esophageal ad.pdf (2.34 MB)
DOCUMENT
Additional file 1. Table S1..docx (15.95 kB)
IMAGE
Additional file 2. Figure S1.tiff (2.3 MB)
1/0
3 files

LC3B globular structures correlate with survival in esophageal adenocarcinoma.

Version 4 2022-11-29, 09:39
Version 3 2022-08-26, 08:27
Version 2 2022-03-08, 13:54
Version 1 2019-11-23, 10:34
journal contribution
posted on 2022-11-29, 09:39 authored by Shereen El-Mashed, Tracey R. O'Donovan, Elaine KayElaine Kay, Ayat R. Abdallah, Mary-Clare Cathcart, Jacintha O'Sullivan, Anthony O'GradyAnthony O'Grady, John Reynolds, Seamus O'Reilly, Gerald C. O'Sullivan, Sharon L. McKenna

Background: Esophageal adenocarcinoma has the fastest growing incidence of any solid tumor in the Western world. Prognosis remains poor with overall five-year survival rates under 25 %. Only a limited number of patients benefit from chemotherapy and there are no biomarkers that can predict outcome. Previous studies have indicated that induction of autophagy can influence various aspects of tumor cell biology, including chemosensitivity. The objective of this study was to assess whether expression of the autophagy marker (LC3B) correlated with patient outcome.

Methods: Esophageal adenocarcinoma tumor tissue from two independent sites, was examined retrospectively. Tumors from 104 neoadjuvant naïve patients and 48 patients post neoadjuvant therapy were assembled into tissue microarrays prior to immunohistochemical analysis. Kaplan-Meier survival curves and log-rank tests were used to assess impact of LC3B expression on survival. Cox regression was used to examine association with clinical risk factors.

Results: A distinct globular pattern of LC3B expression was found to be predictive of outcome in both patient groups, irrespective of treatment (p < 0.001). Multivariate analysis found that this was a strong independent predictor of poor prognosis (p < 0.001).

Conclusions: This distinctive staining pattern of LC3B represents a novel prognostic marker for resectable esophageal adenocarcinoma.

Funding

Egyptian Education Bureau, Higher Education Authority of Ireland, Breakthrough Cancer Research.

History

Comments

The original article is available at www.biomedcentral.com This paper has an erratum that can be found at https://doi.org/10.1186/s12885-019-6410-x. El-Mashed S. et al. Correction to: LC3B globular structures correlate with survival in esophageal adenocarcinoma. BMC Cancer. 2019;19(1):1177.

Published Citation

El-Mashed S. et al. LC3B globular structures correlate with survival in esophageal adenocarcinoma. BMC Cancer. 2015;15:582.

Publication Date

12 August 2015

PubMed ID

26265176

Department/Unit

  • Pathology
  • Beaumont Hospital

Publisher

BioMed Central

Version

  • Published Version (Version of Record)